May 6, 2022 07:06 AM EDT
FDA+
Coronavirus

Safe­ty risk push­es FDA to cut off J&J's Covid-19 vac­cine with some lim­it­ed ex­cep­tions

Zachary Brennan

Senior Editor

Cas­es of a syn­drome with rare and life-threat­en­ing blood clots in com­bi­na­tion with low lev­els of blood platelets war­rant lim­it­ing the au­tho­rized use of J …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times